The association between inflammation and depression was originally discovered in patients receiving long-term IFN-α treatment, and this association suggests that inflammation has an impact on emotional disorders or even acts as a potential pathogenic agent in depression [44, 45]. Here, IFNA1 is linked to depressive symptom measurement.